Sanofi
- Revenue€37.8 BFY, 2021
- Market Capitalization€128.5 B2022-05-27
OverviewSuggest Edit
Sanofi is a global healthcare company engaged in the research, development, manufacture, and marketing of therapeutic solutions. It operates in three core business units: Specialty Care, Vaccines, and General Medicines. The Specialty Care business unit focuses on rare diseases, multiple sclerosis, oncology, immunology, and rare blood disorders. The Vaccines business unit primarily operates through Sanofi Pasteur, a key supplier of life-saving vaccines in both developed and emerging markets. The General Medicines business unit offers treatments for diabetes, cardiovascular, as well as established products. The company also comprises Consumer Healthcare (CHC), a standalone business unit with integrated research, development, manufacturing, support, and information technology capabilities.
| Type | Public | |
| Founded | 2004 | |
| HQ | Paris, FR | Map |
| Website | sanofi.com | |
| Employee Ratings | ||
| Overall Culture | A- | More |
Recent NewsAll News
- Global Osteoarthritis (IA Injections, NSAIDs & Analgesics) Market Research Report 2022-2026 Featuring Johnson & Johnson, Novartis, Bayer, GlaxoSmithKline, Pfizer and Sanofi
- Insights on the Opioids Global Market to 2030 - Featuring Purdue Pharma, AstraZeneca and Sanofi Among Others
- IGM Biosciences Announces Closing of Global Collaboration Agreement with Sanofi
- Denali Therapeutics Announces Achievement of RIPK1 Milestone for Phase 2 Clinical Trial Initiation in ALS by Sanofi
Key People/Management at Sanofi
Paul Hudson
Chief Executive Officer & Director
Serge Weinberg
Chairman of the Board of Directors
Olivier Charmeil
Executive Vice President, General Medicines
Natalie Bickford
Executive Vice President, Chief People Officer
Julie van Ongevalle
Executive Vice President, Consumer Healthcare
Bill Sibold
Executive Vice President Sanofi Genzyme; President, Sanofi North America
Sanofi Office Locations
Sanofi has offices in Paris, Ambarès-et-Lagrave, Amilly, Antony and in 109 other locations
Paris, FR (HQ)
54 Rue la Boétie
Ambarès-et-Lagrave, FR
1 Rue de la Vierge
Amilly, FR
196 Rue du Maréchal Juin
Amilly, FR
748 Rue du Maréchal Juin
Antony, FR
20 Avenue Raymond Aron
Chilly-Mazarin, FR
1 Avenue Pierre Brossolette
Sanofi Financials and Metrics
Sanofi Revenue
Sanofi's revenue was reported to be €37.76 b in FY, 2021
| EUR | |
|---|---|
Revenue (Q1, 2022) | 9.7b |
Gross profit (Q1, 2022) | 7.6b |
Net income (Q1, 2022) | 2.0b |
EBITDA (Q1, 2022) | 2.9b |
EBIT (Q1, 2022) | 2.4b |
Market capitalization (27-May-2022) | 128.5b |
Closing stock price (27-May-2022) | 102.4 |
EV | 128.5b |
Sanofi's current market capitalization is €128.5 b.
Annual
| EUR | FY, 2019 | FY, 2020 | FY, 2021 |
|---|---|---|---|
Revenue | 36.1b | 36.0b | 37.8b |
Cost of goods sold | (10.3b) | (10.5b) | (10.7b) |
Gross profit | 28.7b | 27.5b | 28.9b |
R&D expense | (6.0b) | (5.5b) | (5.7b) |
Quarterly
| EUR | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 | Q1, 2021 | Q2, 2021 | Q3, 2021 | Q1, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 8.4b | 8.6b | 9.5b | 9.0b | 8.2b | 9.5b | 8.6b | 8.7b | 10.4b | 9.7b |
Cost of goods sold | (2.6b) | (1.9b) | (3.1b) | (2.9b) | (1.5b) | (3.2b) | (2.7b) | (1.9b) | (3.2b) | (2.9b) |
Gross profit | 6.2b | 7.7b | 7.0b | 6.7b | 14.5b | 7.0b | 6.5b | 7.3b | 7.9b | 7.6b |
R&D expense | (1.4b) | (1.6b) | (1.4b) | (1.3b) | (1.4b) | (1.3b) | (1.3b) | (1.4b) | (1.4b) | (1.5b) |
Annual
| EUR | FY, 2019 | FY, 2020 | FY, 2021 |
|---|---|---|---|
Cash | 9.4b | 13.9b | 10.1b |
Accounts Receivable | 7.9b | 7.5b | 7.6b |
Prepaid Expenses | 1.9b | 2.4b | 2.0b |
Inventories | 8.0b | 8.4b | 8.7b |
Quarterly
| EUR | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 | Q1, 2021 | Q2, 2021 | Q3, 2021 | Q1, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|
Cash | 6.7b | 16.0b | 9.7b | |||||||
Accounts Receivable | 7.2b | 7.2b | 6.8b | |||||||
Prepaid Expenses | 623.0m | |||||||||
Inventories | 8.4b | 8.9b | 9.3b |
Annual
| EUR | FY, 2019 | FY, 2020 | FY, 2021 |
|---|---|---|---|
Net Income | 2.6b | 12.0b | 6.2b |
Depreciation and Amortization | 7.5b | ||
Inventories | (547.0m) | (593.0m) | (357.0m) |
Accounts Payable | 169.0m | 86.0m | 451.0m |
Quarterly
| EUR | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 | Q1, 2021 | Q2, 2021 | Q3, 2021 | Q1, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 968.0m | 968.0m | 9.0b | 9.0b | 2.8b | 2.8b | ||||
Depreciation and Amortization | 3.8b | 3.8b | 2.0b | 2.0b | 1.7b | 1.7b | ||||
Inventories | (934.0m) | (934.0m) | (1.0b) | (1.0b) | (821.0m) | (821.0m) | ||||
Accounts Payable | (49.0m) | (49.0m) | (325.0m) | (325.0m) | (89.0m) | (89.0m) |
Sanofi Acquisitions / Subsidiaries
| Company Name | Date | Deal Size |
|---|---|---|
| Amunix | December 20, 2021 | $1 b |
| Origimm | December 01, 2021 | |
| Kadmon | September 08, 2021 | $1.9 b |
| Translate Bio | August 03, 2021 | $3.2 b |
| Tidal Therapeutics | April 09, 2021 | $160 m |
| Kymab | January 11, 2021 | $1.1 b |
| Kiadis Pharma | November 02, 2020 | €308 m |
| Principia BioPharma | August 17, 2020 | $3.4 b |
| Synthorx | December 09, 2019 | $2.5 m |
| Ablynx | January 29, 2018 | $4.8 b |
Sanofi Revenue Breakdown
Sanofi revenue breakdown by business segment: 11.8% from HEALTH CARE DIVERSIFIED, 71.4% from PHARMACEUTICALS and 16.7% from VACCINES
Sanofi Cybersecurity Score
Sanofi Environment, Social & Governance (ESG) Ratings
Sanofi Online and Social Media Presence
Sanofi's Trends
Sanofi Company Culture
Overall Culture
A-
75/100
CEO Rating
A
77/100
Compensation
A-
76/100
Diversity
A-
76/100
Sanofi News and Updates
May 18, 2022
Global Osteoarthritis (IA Injections, NSAIDs & Analgesics) Market Research Report 2022-2026 Featuring Johnson & Johnson, Novartis, Bayer, GlaxoSmithKline, Pfizer and Sanofi
DUBLIN, May 18, 2022 /PRNewswire/ -- The "Global Osteoarthritis Market (IA Injections, NSAIDs & Analgesics): Insights, Trends & Forecast (2022-2026)" report has been added to ResearchAndMarkets.com's offering. The global osteoarthritis market revenues are forecasted to touch US$12.14...
May 06, 2022
Insights on the Opioids Global Market to 2030 - Featuring Purdue Pharma, AstraZeneca and Sanofi Among Others
DUBLIN, May 6, 2022 /PRNewswire/ -- The "Opioids Market by Product Type and Application: Global Opportunity Analysis and Industry Forecast, 2021-2030" report has been added to ResearchAndMarkets.com's offering. The global opioids market was valued at $4,412.48 million in 2020, and is...
May 06, 2022
IGM Biosciences Announces Closing of Global Collaboration Agreement with Sanofi
$150 Million Payment to IGM from Sanofi $150 Million Payment to IGM from Sanofi
May 02, 2022
Denali Therapeutics Announces Achievement of RIPK1 Milestone for Phase 2 Clinical Trial Initiation in ALS by Sanofi
SOUTH SAN FRANCISCO, Calif., May 02, 2022 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (NASDAQ: DNLI), a biopharmaceutical company developing a broad portfolio of product candidates engineered to cross the blood-brain barrier (BBB) for neurodegenerative diseases, today announced that its partner S…
April 29, 2022
Sanofi India Q1 Review - Beat On Margins; Strong Recovery Sequentially: Nirmal Bang
Sanofi India Q1 Review - Beat On Margins; Strong Recovery Sequentially: Nirmal Bang
April 28, 2022
Sanofi posts higher earnings and sales, sees further growth ahead
Sanofi posts higher earnings and sales, sees further growth ahead
Sanofi Frequently Asked Questions
When was Sanofi founded?
Sanofi was founded in 2004.
Who are Sanofi key executives?
Sanofi's key executives are Paul Hudson, Serge Weinberg and Olivier Charmeil.
How many employees does Sanofi have?
Sanofi has 95,442 employees.
What is Sanofi revenue?
Latest Sanofi annual revenue is €37.8 b.
What is Sanofi revenue per employee?
Latest Sanofi revenue per employee is €395.6 k.
Who are Sanofi competitors?
Competitors of Sanofi include Viatris, AstraZeneca and Eli Lilly.
Where is Sanofi headquarters?
Sanofi headquarters is located at 54 Rue la Boétie, Paris.
Where are Sanofi offices?
Sanofi has offices in Paris, Ambarès-et-Lagrave, Amilly, Antony and in 109 other locations.
How many offices does Sanofi have?
Sanofi has 119 offices.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies